Infographic: Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE)

Eye, Published online: 20 December 2023; doi:10.1038/s41433-023-02867-4Infographic: Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE)

https://www.nature.com/articles/s41433-023-02867-4

Source: Eye - December 20, 2023 Category: Opthalmology Authors: Naomi Wijesingha Sobha Sivaprasad Source Type: research

More News: Age-Related Macular Degeneration (AMD) | Alfalfa | Opthalmology